• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Respir Res . Association between cytokine profiles and lung injury in COVID-19 pneumonia

tetano

Editor, Senior Moderator
Respir Res


. 2020 Jul 29;21(1):201.
doi: 10.1186/s12931-020-01465-2.
Association between cytokine profiles and lung injury in COVID-19 pneumonia


Li-Da Chen[SUP] 1 [/SUP], Zhen-Yu Zhang[SUP] 2 [/SUP], Xiao-Jie Wei[SUP] 3 [/SUP], Yu-Qing Cai[SUP] 4 [/SUP], Weng-Zhen Yao[SUP] 4 [/SUP], Ming-Hui Wang[SUP] 4 [/SUP], Qiu-Fen Huang[SUP] 4 [/SUP], Xiao-Bin Zhang[SUP] 5 [/SUP]



Affiliations

Abstract

Background: Coronavirus disease 2019 (COVID-19) is a new respiratory and systemic disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. The purpose of the present study was to investigate the association between cytokine profiles and lung injury in COVID-19 pneumonia.
Methods: This retrospective study was conducted in COVID-19 patients. Demographic characteristics, symptoms, signs, underlying diseases, and laboratory data were collected. The patients were divided into COVID-19 with pneumonia and without pneumonia. CT severity score and PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] ratio were used to assess lung injury.
Results: 106 patients with 12 COVID-19 without pneumonia and 94 COVID-19 with pneumonia were included. Compared with COVID-19 without pneumonia, COVID-19 with pneumonia had significantly higher serum interleukin (IL)-2R, IL-6, and tumor necrosis factor (TNF)-α. Correlation analysis showed that CT severity score and PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] were significantly correlated with age, presence of any coexisting disorder, lymphocyte count, procalcitonin, IL-2R, and IL-6. In multivariate analysis, log IL6 was the only independent explanatory variables for CT severity score (β = 0.397, p < 0.001) and PaO[SUB]2[/SUB]/FiO[SUB]2[/SUB] (β = - 0.434, p = 0.003).
Conclusions: Elevation of circulating cytokines was significantly associated with presence of pneumonia in COVID-19 and the severity of lung injury in COVID-19 pneumonia. Circulating IL-6 independently predicted the severity of lung injury in COVID-19 pneumonia.

Keywords: Coronavirus disease 2019; Cytokine; Lung injury; Pneumonia; Severe acute respiratory syndrome coronavirus 2.
 
Back
Top Bottom